A trend toward higher mortality in women with PPM who received a self-expanding valves deserves more scrutiny, though.

New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a ...

Not surprisingly, older patients fared worse, but some older and younger patients saw stroke benefits requiring more study.